Durate
AI NativeDurate helps simplify physician scheduling
Est 2024|Raised $515K
Published Aug 14, 2026
| Starting Price | Not publicly listed | AMiON lists a legacy desktop scheduler fee on its public ordering pages; enterprise pricing is quote-based | Quote-based (public pricing not clearly published) |
| Typical Use Case | Vendor markets automation-led physician scheduling with a mobile interface and integration capabilities | Departments/residency programs that use template-driven schedule creation and self-serve tools | Large organizations seeking broader workforce management including scheduling, credentialing, and time/attendance |
| Key Public Strengths (vendor-claimed / documented) | Natural-language preference capture and automation positioning; SOC 2 Type II attestation is claimed | Established presence and template-based scheduling; vendor adoption claims on public site | Broad platform capabilities and enterprise feature set |
| Key Public Weaknesses / Risks | Limited independent third-party review coverage; pricing not publicly transparent; automation claims not independently validated | Perception of less automation-first approach compared with newer entrants | Community-sourced complaints about pricing and usability; implementations may be resource-intensive |
Where Durate may be competitive (hypothesis based on product messaging and design goals):
Where incumbent vendors often have advantages:
Market adoption signals:
Sources: